Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study Of Subscalp Placement Of The LINQII Device

NCT: NCT07752251 · ENROLLING_BY_INVITATION

NCT IDNCT07752251
StatusENROLLING_BY_INVITATION
Start Date2026-11
Completion2027-11
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this to evaluate the capability of the FDA approved Medtronic LINQ II device (implantable cardiac monitoring device) to record EEG signals when placed temporarily in the subscalp space in patients undergoing cranial neurosurgery. No disease-directed therapeutic efficacy endpoints will be studied.

Frequently Asked Questions

What is A Study Of Subscalp Placement Of The LINQII Device?

A Study Of Subscalp Placement Of The LINQII Device is a clinical trial registered under NCT07752251. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07752251?

The current status of NCT07752251 (A Study Of Subscalp Placement Of The LINQII Device) is: ENROLLING_BY_INVITATION.

When did A Study Of Subscalp Placement Of The LINQII Device start?

A Study Of Subscalp Placement Of The LINQII Device started on 2026-11.

Related Devices

K163460Reveal LINQ Insertable Cardiac MonitorMedtronic, Inc. K200795LINQ II Insertable Cardiac Monitor, LINQ Mobile Manager, Device Command Library, Instrument Command Library, LINQ Tool KitMedtronic, Inc. K210484LINQ II Insertable Cardiac Monitor, Zelda AI ECG Classification SystemMedtronic, Inc. K211304LINQ II Insertable Cardiac MonitorMedtronic, Inc. K212008Reveal LINQ Insertable Cardiac MonitorMedtronic, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑